Kura Oncology Inc (KURA)
Healthcare
Biotechnology
9.20 $
+2.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -86 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26 | -29 | -34 | -49 | -43 | -43 | 269 | -72 | -29 | -81 | 117 | -86 | -78 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 1.7 | 0.4 | 2.4 | |
| 7.0 | 7.1 | 7.2 | 8.5 | 8.4 | 8.3 | 8.6 | 7.8 | 6.9 | 11 | 11 | 8.4 | 38 | |
| 5.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.2 | 1.1 | 3.7 | -4.9 | 3.1 | 0.1 | 282 | -20 | 36 | -44 | 188 | -20 | 159 | |
| 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.4 | 0.3 | 1.5 | 2.6 | 2.3 | 0.1 | 6.5 | |
| -46 | 8.6 | 42 | -95 | 43 | 46 | -95 | -101 | 59 | 94 | -65 | -24 | 64 | |
| 94 | 0.1 | 0.7 | 148 | 3.0 | 2.2 | 0.8 | 0.1 | 0.5 | 0.0 | 1.1 | 0.1 | 1.7 | |
| 22 | -20 | 8.6 | 4.2 | 3.7 | 4.3 | 175 | -173 | 31 | 13 | 54 | -110 | -12 | |
| -26 | -29 | -34 | -49 | -43 | -43 | 269 | -72 | -30 | -83 | 115 | -86 | -84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.